Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

COVID-19 Treatment Trial Reaches Out to Communities of Color

Posted on April 5th, 2021 by in COVID-19

An ongoing problem in clinical trials over the years has been a failure to procure diverse enough representation among the participants. For a long time, this was due to bias and oversight on the part of the research community, and the consequence was a lack of full understanding in how medications and treatments affected women and various racial/ethnic minorities.

(more…)

Harris Poll Finds Large Boost in Pharma Industry Reputation

Posted on March 15th, 2021 by in Pharma R&D

As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna and AstraZeneca with the same ease that they refer to their favorite brands of ketchup or peanut butter. This isn’t typical. While direct-to-consumer advertising has perhaps increased some awareness of drug makers, the pandemic has made pharma R&D a subject of public interest in an unprecedented fashion.

(more…)

What Excites You Most About the Life Sciences Industry in 2021?

Posted on February 19th, 2021 by in Pharma R&D

We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021.

(more…)

What Were the Biggest Advances in Life Sciences in 2020?

Posted on February 8th, 2021 by in Pharma R&D

As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life sciences in 2020.

(more…)

  1. 1
  2. 2
  3. 3
  4. …
  5. 7